Webdisclosure.com

Search

GENFIT (EPA:GNFT) Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC

Directive transparence : information réglementée

07/12/2023 11:15